Literature DB >> 12024689

Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results.

John T Cody1.   

Abstract

Medical Review Officer interpretation of laboratory results is an important component of drug testing programs. The clinical evaluation of laboratory results to assess the possibility of appropriate medical use of a drug is a task with many different facets, depending on the drug class considered. This intercession prevents the reporting of positive results unless it is apparent that drugs were used illicitly. In addition to the commonly encountered prescribed drugs that yield positive drug testing results, other sources of positive results must be considered. This review describes a series of compounds referred to as "precursor" drugs that are metabolized by the body to amphetamine and/or methamphetamine. These compounds lead to positive results for amphetamines even though neither amphetamine nor methamphetamine were used, a possibility that must be considered in the review of laboratory results. Description of the drugs, their clinical indications, and results seen following administration are provided. This information allows for the informed evaluation of results with regard to the potential involvement of these drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12024689     DOI: 10.1097/00043764-200205000-00012

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  6 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

Review 2.  Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

3.  Correlates of nonmedical use of stimulants and methamphetamine use in a national sample.

Authors:  Lian-Yu Chen; Eric C Strain; Pierre Kébreau Alexandre; G Caleb Alexander; Ramin Mojtabai; Silvia S Martins
Journal:  Addict Behav       Date:  2014-02-12       Impact factor: 3.913

4.  A comparative analysis of protein targets of withdrawn cardiovascular drugs in human and mouse.

Authors:  Yuqi Zhao; Jingwen Wang; Yanjie Wang; Jingfei Huang
Journal:  J Clin Bioinforma       Date:  2012-05-01

5.  Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring.

Authors:  Iria González-Mariño; Jose Antonio Baz-Lomba; Nikiforos A Alygizakis; Maria Jesús Andrés-Costa; Richard Bade; Anne Bannwarth; Leon P Barron; Frederic Been; Lisa Benaglia; Jean-Daniel Berset; Lubertus Bijlsma; Igor Bodík; Asher Brenner; Andreas L Brock; Daniel A Burgard; Erika Castrignanò; Alberto Celma; Christophoros E Christophoridis; Adrian Covaci; Olivier Delémont; Pim de Voogt; Damien A Devault; Mário J Dias; Erik Emke; Pierre Esseiva; Despo Fatta-Kassinos; Ganna Fedorova; Konstantinos Fytianos; Cobus Gerber; Roman Grabic; Emma Gracia-Lor; Stefan Grüner; Teemu Gunnar; Evroula Hapeshi; Ester Heath; Björn Helm; Félix Hernández; Aino Kankaanpaa; Sara Karolak; Barbara Kasprzyk-Hordern; Ivona Krizman-Matasic; Foon Yin Lai; Wojciech Lechowicz; Alvaro Lopes; Miren López de Alda; Ester López-García; Arndís S C Löve; Nicola Mastroianni; Gillian L McEneff; Rosa Montes; Kelly Munro; Thomas Nefau; Herbert Oberacher; Jake W O'Brien; Reinhard Oertel; Kristin Olafsdottir; Yolanda Picó; Benedek G Plósz; Fabio Polesel; Cristina Postigo; José Benito Quintana; Pedram Ramin; Malcolm J Reid; Jack Rice; Rosario Rodil; Noelia Salgueiro-González; Sara Schubert; Ivan Senta; Susana M Simões; Maja M Sremacki; Katarzyna Styszko; Senka Terzic; Nikolaos S Thomaidis; Kevin V Thomas; Ben J Tscharke; Robin Udrisard; Alexander L N van Nuijs; Viviane Yargeau; Ettore Zuccato; Sara Castiglioni; Christoph Ort
Journal:  Addiction       Date:  2019-10-23       Impact factor: 7.256

6.  Mitigated Oxidative Stress and Cognitive Impairments in Transient Global Ischemia using Niosomal Selegiline-NBP delivery.

Authors:  Bahareh Jafari; Mahmoud Gharbavi; Yasamin Baghdadchi; Hamidreza Kheiri Manjili; Javad Mahmoudi; Iraj Jafari-Anarkoli; Shayan Amiri; Mir-Jamal Hosseini
Journal:  Behav Neurol       Date:  2022-04-16       Impact factor: 3.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.